Short answer · Medically reviewed summary · Last updated: 2026-05-08
Mitral Valve Prolapse Syndrome was first clinically characterized in the 1960s, evolving from a misunderstood murmur to a well-defined structural heart condition. Today, we understand Mitral Valve Prolapse Syndrome as a common valvular abnormality, affecting approximately 2% to 3% of the general population, with significant advancements in echocardiographic imaging guiding its modern management. How was Mitral Valve Prolapse Syndrome first identified? While physicians had noted the "click-murmur" sound during heart examinations as early as the 19th century, it was not until 1963 that Dr.
What is the history of Mitral Valve Prolapse Syndrome?
History of Mitral Valve Prolapse Syndrome: when and how it was discovered, and the milestones in research since, medically reviewed.
Mitral Valve Prolapse Syndrome was first clinically characterized in the 1960s, evolving from a misunderstood murmur to a well-defined structural heart condition. Today, we understand Mitral Valve Prolapse Syndrome as a common valvular abnormality, affecting approximately 2% to 3% of the general population, with significant advancements in echocardiographic imaging guiding its modern management.
How was Mitral Valve Prolapse Syndrome first identified?
While physicians had noted the "click-murmur" sound during heart examinations as early as the 19th century, it was not until 1963 that Dr. John Barlow and his colleagues in South Africa published the seminal paper linking these specific sounds to the ballooning of the mitral valve leaflets into the left atrium. Before this, these sounds were often misdiagnosed as rheumatic heart disease or benign functional murmurs.
How has our understanding of the condition evolved?
In the 1970s and 1980s, Mitral Valve Prolapse Syndrome was frequently over-diagnosed due to the subjective nature of early echocardiography. This era saw the "prolapse craze," where many patients were incorrectly labeled with the condition. Since the 1990s, stricter diagnostic criteria—specifically the measurement of leaflet displacement—have helped clinicians distinguish between clinically significant Mitral Valve Prolapse Syndrome and benign valvular variations.
What are the major milestones in treatment and diagnosis?
The medical approach to Mitral Valve Prolapse Syndrome has shifted from surgical intervention to a focus on risk stratification:
- 1960s: Initial identification of the "Barlow’s syndrome" click-murmur.
- 1970s: The advent of M-mode echocardiography allowed for the first non-invasive visual confirmation.
- 1990s: Development of standardized criteria to prevent over-diagnosis.
- 2000s–Present: Refinement of mitral valve repair techniques, which are now preferred over replacement to preserve heart function.
How does modern genetics impact the view of this disease?
We now know that Mitral Valve Prolapse Syndrome often has a familial component, frequently appearing in patients with connective tissue disorders like Marfan syndrome. Modern genetic research has identified specific chromosomal loci, helping us understand that Mitral Valve Prolapse Syndrome is not a single disease but a spectrum of conditions involving collagen abnormalities.
Next steps
- Consult a cardiologist to discuss your specific echocardiogram findings.
- Join our community of 23 members at DiseaseMaps.org to share experiences and coping strategies.
- Monitor for symptoms like palpitations or shortness of breath and document them for your specialist.
Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician regarding a medical condition.
References
- NIH Genetic and Rare Diseases Information Center (GARD): Mitral Valve Prolapse.
- Orphanet: Rare diseases database and clinical information.
- OMIM (Online Mendelian Inheritance in Man): Entry #157700.
- American Heart Association (AHA): Valvular Heart Disease Guidelines.
